Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Quest PharmaTech Inc V.QPT

Alternate Symbol(s):  QPTFF

Healthcare Biotechnology
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Current News (TSXV:QPT)

Quest PharmaTech Announces Results from AGM

GlobeNewswire August 27, 2025

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

GlobeNewswire June 10, 2025

Quest PharmaTech Provides Corporate Update

GlobeNewswire June 2, 2025

Quest PharmaTech Announces Results from AGM

GlobeNewswire October 11, 2024

Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director

Canada NewsWire May 30, 2024

Quest Receives Cash Dividend Payment from OncoQuest

Canada NewsWire January 30, 2024

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

Canada NewsWire January 23, 2024

Quest PharmaTech Provides Corporate Update

Canada NewsWire September 13, 2023

Quest PharmaTech Announces Results from AGM

Canada NewsWire July 14, 2023
View More News ››

Opinion & Analysis (TSXV:QPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:QPT)

RE:RE:RE:RE:If the only reason oregovomab failed futility analysis....

To Recap: The global Phase 3 clinical trial of oregovomab (FLORA-5) for newly diagnosed advanced ovarian cancer patients...
G1945V - November 23, 2025

RE:RE:RE:If the only reason oregovomab failed futility analysis....

This is my understanding : Both the Phase 2 and Phase 3 trials of oregovomab compared the combination of carboplatin, paclitaxel, and...
G1945V - November 23, 2025

RE:RE:If the only reason oregovomab failed futility analysis....

Gemini: The overall survival (OS) hazard ratio (HR) for oregovomab in the randomized Phase II study (QPT-ORE-002) of front-line chemo...
TrickyGame - November 22, 2025

RE:If the only reason oregovomab failed futility analysis....

The reported overall survival hazard ratio (HR) in Phase 2 was approximately 0.75, indicating a 25% reduction in the risk of death...
G1945V - November 22, 2025

If the only reason oregovomab failed futility analysis....

Regardless of who says what on the issue or the susposed blame if it is true that the ONLY reason oregovomab failed the P3 futility...
TrickyGame - November 20, 2025

EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE)

EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the...
G1945V - August 28, 2025
View more Bullboard ››

Mullen Group Ltd

Mullen Group Ltd

Mullen Group Ltd. provides a range of trucking and logistics services in Canada and the United States. It operates through ...
View More »

Podcasts